Cargos activos de Jeffrey Levitt
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
STEMLINE THERAPEUTICS, INC. | Oficial de Cumplimiento | 01/04/2021 | - |
Consejero General | 01/03/2018 | - |
Historial de carrera de Jeffrey Levitt
Estadísticas
Internacional
Estados Unidos | 2 |
Operativa
Compliance Officer | 1 |
General Counsel | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignancies. The SL-801, is a novel oral small molecule reversible inhibitor of XPO1, that has demonstrated in vivo and in vitro preclinical activity in solid and hematologic malignancies. The SL-701, is an immunotherapy designed to activate the immune system to attack tumors. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Jeffrey Levitt
- Experiencia